SPI Pharma News and Resources

SPI Pharma and Inimmune Corp. have announced a partnership to develop and commercialise advanced adjuvant systems for vaccine development. The collaboration leverages Inimmune’s expertise in adjuvant formulation and immunotherapeutics alongside SPI Pharma’s manufacturing and global commercial capabilities. Adjuvant systems are